- Home
- KNW vs SABS Comparison
KNW vs SABS Comparison
Compare KNW & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNW
- SABS
- Stock Information
- Founded
- KNW 1998
- SABS 2014
- Country
- KNW United States
- SABS United States
- Employees
- KNW N/A
- SABS N/A
- Industry
- KNW Industrial Machinery/Components
- SABS Biotechnology: Pharmaceutical Preparations
- Sector
- KNW Industrials
- SABS Health Care
- Exchange
- KNW Nasdaq
- SABS Nasdaq
- Market Cap
- KNW 25.6M
- SABS 23.9M
- IPO Year
- KNW N/A
- SABS N/A
- Fundamental
- Price
- KNW $0.25
- SABS $3.13
- Analyst Decision
- KNW Buy
- SABS Strong Buy
- Analyst Count
- KNW 1
- SABS 5
- Target Price
- KNW $1.00
- SABS $12.40
- AVG Volume (30 Days)
- KNW 184.3K
- SABS 83.6K
- Earning Date
- KNW 11-15-2024
- SABS 11-06-2024
- Dividend Yield
- KNW N/A
- SABS N/A
- EPS Growth
- KNW N/A
- SABS N/A
- EPS
- KNW N/A
- SABS N/A
- Revenue
- KNW N/A
- SABS $1,512,723.00
- Revenue This Year
- KNW N/A
- SABS N/A
- Revenue Next Year
- KNW N/A
- SABS N/A
- P/E Ratio
- KNW N/A
- SABS N/A
- Revenue Growth
- KNW N/A
- SABS N/A
- 52 Week Low
- KNW $0.18
- SABS $2.16
- 52 Week High
- KNW $0.94
- SABS $9.72
- Technical
- Relative Strength Index (RSI)
- KNW 55.17
- SABS 48.83
- Support Level
- KNW $0.20
- SABS $2.95
- Resistance Level
- KNW $0.28
- SABS $3.74
- Average True Range (ATR)
- KNW 0.02
- SABS 0.43
- MACD
- KNW 0.00
- SABS -0.07
- Stochastic Oscillator
- KNW 57.38
- SABS 13.14
About KNW Know Labs Inc.
Know Labs Inc is a medical diagnostic. The company is focused on the development, marketing, and sales of proprietary technologies that are capable of uniquely identifying or authenticating almost any substance or material using electromagnetic energy to record, detect, and identify the signature of the substance or material known as Bio-RFID and ChromaID technologies. It is developing a wearable device that will measure blood glucose without fingersticks or microneedles.
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.